Inflammatory mediators of systemic inflammation in neonatal sepsis

被引:0
作者
V. Sugitharini
A. Prema
E. Berla Thangam
机构
[1] School of Bioengineering,Department of Biotechnology
[2] SRM University,Department of Pediatrics
[3] SRM Medical College Hospital and Research Centre,undefined
来源
Inflammation Research | 2013年 / 62卷
关键词
Neonatal sepsis; Inflammatory mediators; Cytokines; Acute phase proteins;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1025 / 1034
页数:9
相关论文
共 243 条
[31]  
Moutardier V(1985)A combined score of pro- and anti inflammatory interleukins improves mortality prediction in severe sepsis Blood 14 e806-1132
[32]  
Blache JL(2010)Leukocyte–endothelial interactions Int J Infect Dis 140 55-818
[33]  
Weinberg GA(2012)Circulating concentrations of α- and β-chemokines in neonatal sepsis J Ethnopharmacol 127 547-157
[34]  
D’Angio CT(2002)In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte–endothelial cell adhesion and VCAM-1 gene expression Clin Exp Immunol 31 207-271
[35]  
Riedemann NC(1996)Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGFbeta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals Exp Gerontol 173 1121-112
[36]  
Goo RF(1991)Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts J Exp Med 102 927-7160
[37]  
Ward PA(1998)Transforming growth factor beta 1(TGFbeta 1) induced neutrophil recruitment to synovial tissues: implications for TGFbeta-driven synovial inflammation and hyperplasia Pediatrics 46 212-4855
[38]  
Aziz M(1995)Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1 J Inflamm 91 92-undefined
[39]  
Jacob A(2002)Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure Acta Paediatr Suppl 8 810-undefined
[40]  
Yang WL(2008)Inflammatory mediators in perinatal asphyxia and infection Int Immunopharmacol 11 R49-undefined